Variant report
Variant | nsv1026647 |
---|---|
Chromosome Location | chr9:10541916-10565964 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375042553 | chr9:10543611-10543612 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368905945 | chr9:10543622-10543623 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548540981 | chr9:10543628-10543629 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148662726 | chr9:10543639-10543640 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142191245 | chr9:10543663-10543664 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543939875 | chr9:10543692-10543693 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187750284 | chr9:10543712-10543713 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553321501 | chr9:10543720-10543721 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs151196594 | chr9:10543759-10543760 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192316313 | chr9:10543760-10543761 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73396244 | chr9:10543802-10543803 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs559976126 | chr9:10543835-10543836 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73396249 | chr9:10543846-10543847 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs552326249 | chr9:10543853-10543854 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184741273 | chr9:10543861-10543862 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139735176 | chr9:10543871-10543872 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538697937 | chr9:10543882-10543883 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143714597 | chr9:10543895-10543896 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10959161 | chr9:10543899-10543900 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs534140101 | chr9:10543909-10543910 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561873692 | chr9:10543924-10543925 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547850036 | chr9:10543935-10543936 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377463246 | chr9:10543941-10543942 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538443424 | chr9:10543945-10543946 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371161311 | chr9:10543980-10543981 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373538994 | chr9:10543989-10543990 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375371380 | chr9:10548431-10548432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577337376 | chr9:10548442-10548443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138062824 | chr9:10548448-10548449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558191449 | chr9:10548493-10548494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552174587 | chr9:10548522-10548523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191072286 | chr9:10548533-10548534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543805458 | chr9:10548535-10548536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554173957 | chr9:10548548-10548549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574661658 | chr9:10548565-10548566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540122709 | chr9:10548571-10548572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148869591 | chr9:10548616-10548617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369692757 | chr9:10548618-10548619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560420220 | chr9:10548621-10548622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182414474 | chr9:10548684-10548685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546018358 | chr9:10548728-10548729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568163452 | chr9:10548747-10548748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199500596 | chr9:10548748-10548749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs33948585 | chr9:10548749-10548750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112186177 | chr9:10548778-10548779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185561330 | chr9:10548786-10548787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548586927 | chr9:10548797-10548798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557108406 | chr9:10555417-10555418 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573991166 | chr9:10555452-10555453 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536515904 | chr9:10555455-10555456 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10543600-10544000 | Active TSS | Aorta | Aorta |
2 | chr9:10548400-10548800 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr9:10548400-10548800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr9:10548400-10548800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr9:10555400-10555600 | Bivalent Enhancer | Esophagus | oesophagus |
6 | chr9:10556800-10557600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr9:10556800-10557600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr9:10557200-10557600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr9:10557200-10557600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr9:10557400-10557800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr9:10557600-10558000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr9:10561400-10564200 | Enhancers | NHEK | skin |
13 | chr9:10561600-10562200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr9:10562000-10562800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr9:10562200-10562600 | Enhancers | HMEC | breast |
16 | chr9:10562200-10563800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr9:10562600-10563000 | Weak transcription | HMEC | breast |
18 | chr9:10562800-10563200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr9:10563000-10564200 | Enhancers | HMEC | breast |
20 | chr9:10563200-10563600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr9:10563800-10564200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |